Cannabis has been used for centuries to treat seizures. Recent anecdotal reports,
accumulating animal model data, and mechanistic insights have raised interest in cannabis …

Recently, cannabis has been suggested as a potential alternative therapy for refractory
epilepsy, which affects 30% of epilepsy, both adults and children, who do not respond to …

The interest in cannabis-based products for the treatment of refractory epilepsy has
skyrocketed in recent years. Marijuana and other cannabis products with high content in Δ …

The antiepileptic potential of Cannabis sativa preparations has been historically recognized.
Recent changes in legal restrictions and new well-documented cases reporting remarkably …

Epilepsy is a chronic disease characterized by recurrent unprovoked seizures. Up to 30% of
children with epilepsy will be refractory to standard anticonvulsant therapy, and those with …

The isolation and identification of the discrete plant cannabinoids in marijuana revived
interest in analyzing historical therapeutic claims made for cannabis in clinical case studies …

Cannabis sativa has been associated with contradictory effects upon seizure states despite
its medicinal use by numerous people with epilepsy. We have recently shown that the …

Abstract Purpose of Review For millennia, there has been interest in the use of cannabis for
the treatment of epilepsy. However, it is only recently that appropriately powered controlled …

Epilepsy is a neurological disorder characterized by the presence of seizures and
neuropsychiatric comorbidities. Despite the number of antiepileptic drugs, one-third of …

Cannabis-derived cannabinoids have neuroactive properties. Recently, there has been
emerging interest in the use of cannabidiol (CBD)-enriched products for treatment of drug …